Applied Clinical Trials Digital Edition - April 2011

Article

Applied Clinical Trials

Applied Clinical TrialsApplied Clinical Trials-04-01-2011
Volume 20
Issue 4

GLOBAL TRIALS : Trials in the Middle East and North Africa Historical Overview: United Kingdom Trials KKS Network Increases Output in Germany Also in this issue : Presidential Panel Considers Tighter Rules, European Union Provides Guidance, Natural Language Processing, Reducing Costs Through Technology

External Link - article-821538.pdf

Download Issue PDF
Articles in this issue
Applied Clinical Trials Digital Edition - April 2011
i4-714696-1408620528636.jpg
Business and News Update April 2011
Demystifying Asian Trials
i8_t-716474-1408621842996.jpg
Academic Strength in Germany
Imaging CROs in Asia
i1-714705-1408620486134.jpg
Sponsor Oversight of CROs
i1-714702-1408620500452.jpg
Clinical Research Ethics, Oversight Draws Scrutiny
i1-714699-1408620517902.jpg
Mining for Words: The Case for NLP
MENA: The Dawn of a New Era
MENA: The Dawn of a New Era
i1-714692-1408620545231.jpg
Diagnosis on the Run: There's an App for That
i1-714693-1408620541976.jpg
Darwin at Work: Trial Technology
i1-714700-1408620513459.jpg
Alzheimer's Advances Depend on Early Diagnosis
i1-714697-1408620526408.jpg
Act cover
Research in the United Kingdom
Research in the United Kingdom
Researchers Tackle Problems in Bowel Disease
Recent Videos
Related Content
Preparing to Achieve with Joint Clinical Assessments

Preparing to Achieve with Joint Clinical Assessments

Graham Bell
June 11th 2025
Article

Strategies for sponsors in navigating the European Union's new health technology assessment regulation.

Unifying Industry to Better Understand GCP Guidance

Unifying Industry to Better Understand GCP Guidance

Andy Studna, Senior Editor
May 7th 2025
Podcast

In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.

What We Think We Know: How Overconfidence Derails Clinical Trials

What We Think We Know: How Overconfidence Derails Clinical Trials

Brian S. McGowan, PhD, FACEHP
June 11th 2025
Article

Overcoming the illusion of knowledge in clinical research can enhance decision-making, training, and project success—helping ensure trials run smoothly and effectively.

Site Logo

Unlock Commercial Growth through Data-Driven Patient and HCP Insights Podcast

May 2nd 2025
Podcast
© LASZLO - © LASZLO - stock.adobe.com.

First Patient Dosed in Phase III Trial of Enhertu as First-Line Treatment for Endometrial Cancer

Andy Studna, Senior Editor
June 10th 2025
Article

In combination with rilvegostomig or Keytruda, Enhertu will be evaluated versus chemotherapy in the DESTINY-Endometrial01 study for the treatment of patients with HER2-expressing, mismatch repair proficient primary advanced or recurrent endometrial cancer.

Credit: Dr_Microbe | stock.adobe.com. Lung cancer, medical concept, 3D illustration showing cancerous tumor inside human lung

Phase III DeLLphi-304 Trial Finds Imdelltra Significantly Extends Survival in Relapsed Small-Cell Lung Cancer

Davy James
June 10th 2025
Article

Phase III DeLLphi-304 results show T-cell engager Imdelltra (tarlatamab) delivers superior overall survival, improved progression-free survival, and better symptom control compared to chemotherapy in patients with small-cell lung cancer following platinum-based treatment.

© 2025 MJH Life Sciences

All rights reserved.